CIHD Virtual Seminar Series: Shannon Buckley

September 10 at 9:00am MT

Catagories

Seminar Series

UBR5-mediated bone marrow failure and myelodysplastic syndromes by Shannon Buckley, Ph.D. University of Utah School of Medicine and Huntsman Cancer Institute


CIHD Virtual Seminar Series 2024-2025

NIDDk-Sponsored Center for Iron & Hematology Disorders at The University of Utah

Second Tuesday of the Month (*exception)

9:00 AM MT


  • Sep 10

    Shannon Buckley, Ph.D.

    University of Utah School of Medicine and Huntsman Cancer Institute

    UBR5-mediated bone marrow failure and myelodysplastic syndromes


  • Oct 8

    Merav Socolovsky, MBBS, Ph.D.

    University of Massachusetts Chan Medical School

    The role of the cell cycle in erythroid differentiation


  • Nov 12

    Hongying Shen, Ph.D.

    Yale School of Medicine

    Dual regulation of SLC25A39 by AFG3L2 and iron controls mitochondrial glutathione homeostasis



  • Jan 14

    Kimberley O’Brien, Ph.D.

    Cornell University

    Determinants of Maternal-Fetal Iron Partitioning – New Approaches and Unresolved Questions


    Feb 11

    Yelena Ginzburg, M.D.

    Icahn School of Medicine at Mount Sinai and The Tisch Cancer Institute

    Iron Chelation Improves Erythropoiesis in Myelodysplastic Syndrome


  • Mar 11

    Tina Termini, Ph.D.

    Fred Hutchinson Cancer Institute

    Disentangling the function of Syndecan-2 in hematopoiesis


    *Apr 15

    Angelo D’Alessandro, Ph.D.

    University of Colorado Anschutz Medical Campus

    Ferroptosis in red cell aging


  • May 13

    Massiel Chavez Stolla, Ph.D.

    University of Washington

    Autophagy ATG4A in normal and impaired erythropoiesis


See original Post




How to Attend

Online

https://utah.zoom.us/j/92155616298

CIHD Virtual Seminar Series 2024-2025

NIDDk-Sponsored Center for Iron & Hematology Disorders at The University of Utah

Second Tuesday of the Month (*exception)

9:00 AM MT


  • Sep 10

    Shannon Buckley, Ph.D.

    University of Utah School of Medicine and Huntsman Cancer Institute

    UBR5-mediated bone marrow failure and myelodysplastic syndromes


  • Oct 8

    Merav Socolovsky, MBBS, Ph.D.

    University of Massachusetts Chan Medical School

    The role of the cell cycle in erythroid differentiation


  • Nov 12

    Hongying Shen, Ph.D.

    Yale School of Medicine

    Dual regulation of SLC25A39 by AFG3L2 and iron controls mitochondrial glutathione homeostasis



  • Jan 14

    Kimberley O’Brien, Ph.D.

    Cornell University

    Determinants of Maternal-Fetal Iron Partitioning – New Approaches and Unresolved Questions


    Feb 11

    Yelena Ginzburg, M.D.

    Icahn School of Medicine at Mount Sinai and The Tisch Cancer Institute

    Iron Chelation Improves Erythropoiesis in Myelodysplastic Syndrome


  • Mar 11

    Tina Termini, Ph.D.

    Fred Hutchinson Cancer Institute

    Disentangling the function of Syndecan-2 in hematopoiesis


    *Apr 15

    Angelo D’Alessandro, Ph.D.

    University of Colorado Anschutz Medical Campus

    Ferroptosis in red cell aging


  • May 13

    Massiel Chavez Stolla, Ph.D.

    University of Washington

    Autophagy ATG4A in normal and impaired erythropoiesis


See original Post